Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2000

View Archived Issues

Positive interim phase I/II data shown for Multikine in head and neck cancer

HumaRAD pilot clinical results reported for head and neck cancer

Cypress Bioscience expands Prosorba Column pilot program

MSI-ipratropium trial reveals efficacy of new delivery system

Insulin and sildenafil restore gastrointestinal function in diabetic mice

Suppression of mitochondrial respiration linked to osteoarthritis

Chemotherapy of head and neck cancer enhanced by gene therapy

Tamoxifen plus cisplatin improves survival in melanoma patients

CNS-reactive human MAbs promote remyelination in MS model

Genasense receives orphan drug status for treatment of malignant melanoma

MediChem-AstraZeneca collaboration extended

Phase II study of clenoliximab in rheumatoid arthritis begins

Collateral expands research collaboration with NYU

Sankyo develops rosiglitazone analogues with hypoglycemic activities

Novel growth factor receptor inhibitors described by Sugen

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Pulmicort Respules approved in U.S. for children aged 1 to 8 years

New peptides under development at Ludwig Institute

Roche discloses new series of IP receptor agonists

New antiangiogenic agents under development at Merck KGaA

Nycomed Imaging describes new compounds as contrast media

MTP inhibitors under development at Janssen

New polypeptides useful for treatment of metastases

Kogenate Bayer approved in E.U. for hemophilia A

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...